But a new threat has emerged from proposed FDA regulation. Pacific Edge has opportunity to overturn the Novitas decision. News this week that the withdrawal of Medicare insurance coverage for Pacific Edge's Cxbladder tests has been delayed is a win for the company but there are still a wide range of potential outcomes, Craigs research analyst Rob Morrison says. Novitas, the Medicare Administrative Contractor (MAC) Want to read more? It's easy. Choose your best value subscription option Individual Group membership NBR Marketplace NZ Aviation News $35 per user - Pay by monthly credit card debit $30 per user - Pay by monthly credit card debit $25 per user - Pay by monthly credit card debit $18.

https://www.nbr.co.nz/tech/pacific-edges-medicare-coverage-could-be-regained-analyst-says/

#nbr